Kirstie S. Opstad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kirstie S. Opstad has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Franklyn Arron Howe
Neuroscience & Cell Biology Research Institute, School of Health and Medical Sciences, City St George's, University of London, SW17 ORE, UK
7 shared publications B. Anthony Bell
Academic Neurosurgery Unit, St George's, University of London, London, UK
5 shared publicationsJohn R. Griffiths
Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
5 shared publicationsAlan J. Wright
Division of Basic Medical Sciences, St George's, University of London, London, UK
1 shared publicationB A Bell
Academic Neurosurgery Unit, St George's, University of London Cranmer Terrace, London SW17 0RE, UK
1 shared publicationB. A. Bell
Academic Neurosurgery Unit, St George's University of London, London SW17 0RE, UK
1 shared publication
Latest Publications
- 2 September 2011
- Published by Springer Nature
- p. 121-128
Astrocytomas: Role of Taurine in Apoptosis Using Magnetic Resonance Spectroscopy
- 2 September 2011
- Published by Springer Nature
- p. 121-128
Astrocytomas: Role of Taurine in Apoptosis Using Magnetic Resonance Spectroscopy
- 23 January 2010
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 31 (2) , 289-297
Correlations between in vivo 1H MRS and ex vivo 1H HRMAS metabolite measurements in adult human gliomas
Purpose: To assess how accurately ex vivo high‐resolution magic angle spinning (HRMAS) proton magnetic resonance spectroscopy (1H MRS) from small biopsy tissues relate to in vivo 1H MRS (from larger tumor volumes) in human astrocytomas.Materials and Methods: In vivo (PRESS, TE = 30 msec) and ex vivo (presaturation) 1H spectra of 17 human astrocytomas (4 grade II, 1 grade III and 12 glioblastomas) were quantified using LCModel. Concentrations of 11 metabolites and 2 lipid/macromolecules were retrospectively compared, with histogram analysis of the in vivo MRI data used to evaluate tumor heterogeneity.Results: For homogeneous‐appearing tumors, significant correlations were found between in vivo and ex vivo 1H MRS concentrations of those metabolites known to be metabolically stable in postmortem tissues (eg, creatine, myo‐inositol, total cholines, and the ≈1.3 and 0.9 ppm lipids). Anaerobic glycolysis during biopsy surgical removal depletes the tissue of glucose, increasing alanine and lactate, and resulted in no correlation between these in vivo and ex vivo metabolite concentrations.Conclusion: Within defined limitations, ex vivo astrocytoma biopsy HRMAS 1H spectra have similar metabolic profiles to that obtained in vivo and therefore detailed ex vivo characterization of glioma biopsies can directly relate to the original tumor. J. Magn. Reson. Imaging 2010; 31: 289–297.
- 23 January 2010
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 31 (2) , 289-297
Correlations between in vivo 1H MRS and ex vivo 1H HRMAS metabolite measurements in adult human gliomas
Purpose: To assess how accurately ex vivo high‐resolution magic angle spinning (HRMAS) proton magnetic resonance spectroscopy (1H MRS) from small biopsy tissues relate to in vivo 1H MRS (from larger tumor volumes) in human astrocytomas.Materials and Methods: In vivo (PRESS, TE = 30 msec) and ex vivo (presaturation) 1H spectra of 17 human astrocytomas (4 grade II, 1 grade III and 12 glioblastomas) were quantified using LCModel. Concentrations of 11 metabolites and 2 lipid/macromolecules were retrospectively compared, with histogram analysis of the in vivo MRI data used to evaluate tumor heterogeneity.Results: For homogeneous‐appearing tumors, significant correlations were found between in vivo and ex vivo 1H MRS concentrations of those metabolites known to be metabolically stable in postmortem tissues (eg, creatine, myo‐inositol, total cholines, and the ≈1.3 and 0.9 ppm lipids). Anaerobic glycolysis during biopsy surgical removal depletes the tissue of glucose, increasing alanine and lactate, and resulted in no correlation between these in vivo and ex vivo metabolite concentrations.Conclusion: Within defined limitations, ex vivo astrocytoma biopsy HRMAS 1H spectra have similar metabolic profiles to that obtained in vivo and therefore detailed ex vivo characterization of glioma biopsies can directly relate to the original tumor. J. Magn. Reson. Imaging 2010; 31: 289–297.
- Open Access
- 17 February 2009
- Published by Springer Nature in British Journal of Cancer
- Vol. 100 (5) , 789-794
Taurine: a potential marker of apoptosis in gliomas
New cancer therapies are being developed that trigger tumour apoptosis and an in vivo method of apoptotic detection and early treatment response would be of great value. Magnetic resonance spectroscopy (MRS) can determine the tumour biochemical profile in vivo, and we have investigated whether a specific spectroscopic signature exists for apoptosis in human astrocytomas. High-resolution magic angle spinning (HRMAS) 1H MRS provided detailed 1H spectra of brain tumour biopsies for direct correlation with histopathology. Metabolites, mobile lipids and macromolecules were quantified from presaturation HRMAS 1H spectra acquired from 41 biopsies of grades II (n=8), III (n=3) and IV (n=30) astrocytomas. Subsequently, TUNEL and H&E staining provided quantification of apoptosis, cell density and necrosis. Taurine was found to significantly correlate with apoptotic cell density (TUNEL) in both non-necrotic (R=0.727, P=0.003) and necrotic (R=0.626, P=0.0005) biopsies. However, the ca 2.8 p.p.m. polyunsaturated fatty acid peak, observed in other studies as a marker of apoptosis, correlated only in non-necrotic biopsies (R=0.705, P1H MRS signal in astrocytomas may be a robust apoptotic biomarker that is independent of tumour necrotic status.
- 17 February 2009
- Published by Springer Nature in British Journal of Cancer
- Vol. 100 (5) , 789-794
Open AccessTaurine: a potential marker of apoptosis in gliomas
New cancer therapies are being developed that trigger tumour apoptosis and an in vivo method of apoptotic detection and early treatment response would be of great value. Magnetic resonance spectroscopy (MRS) can determine the tumour biochemical profile in vivo, and we have investigated whether a specific spectroscopic signature exists for apoptosis in human astrocytomas. High-resolution magic angle spinning (HRMAS) 1H MRS provided detailed 1H spectra of brain tumour biopsies for direct correlation with histopathology. Metabolites, mobile lipids and macromolecules were quantified from presaturation HRMAS 1H spectra acquired from 41 biopsies of grades II (n=8), III (n=3) and IV (n=30) astrocytomas. Subsequently, TUNEL and H&E staining provided quantification of apoptosis, cell density and necrosis. Taurine was found to significantly correlate with apoptotic cell density (TUNEL) in both non-necrotic (R=0.727, P=0.003) and necrotic (R=0.626, P=0.0005) biopsies. However, the ca 2.8 p.p.m. polyunsaturated fatty acid peak, observed in other studies as a marker of apoptosis, correlated only in non-necrotic biopsies (R=0.705, P1H MRS signal in astrocytomas may be a robust apoptotic biomarker that is independent of tumour necrotic status.
- 3 October 2008
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 60 (5) , 1237-1242
Toward accurate quantification of metabolites, lipids, and macromolecules in HRMAS spectra of human brain tumor biopsies using LCModel
High‐resolution magic angle spinning (HRMAS) 1H MR spectroscopy of biopsy samples provides detailed biochemical profiles that can be related to the lower‐resolution spectra obtained in vivo. Nevertheless, there is still significant overlap of many resonance peaks and contributions from broad lipid and macromolecule resonances that impede accurate quantification. We determined a minimum set of in vitro metabolite and simulated lipid and macromolecule resonances needed for LCModel analysis and quantification of brain tumor biopsy HRMAS spectra. We also demonstrate the quality of the LCModel fit for the four main brain tumor types (astrocytoma grade II, glioblastoma, metastasis, and meningioma). Our data suggest that when fitting resonances of coupled spins systems in high‐resolution spectra, interactions between metabolites and the macromolecular environment of the biopsy may cause small peak shifts not found in the solution spectra. However, LCModel is shown to provide a user‐independent method of analyzing HRMAS brain tumor spectra. Magn Reson Med, 2008.
- 3 October 2008
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 60 (5) , 1237-1242
Toward accurate quantification of metabolites, lipids, and macromolecules in HRMAS spectra of human brain tumor biopsies using LCModel
High‐resolution magic angle spinning (HRMAS) 1H MR spectroscopy of biopsy samples provides detailed biochemical profiles that can be related to the lower‐resolution spectra obtained in vivo. Nevertheless, there is still significant overlap of many resonance peaks and contributions from broad lipid and macromolecule resonances that impede accurate quantification. We determined a minimum set of in vitro metabolite and simulated lipid and macromolecule resonances needed for LCModel analysis and quantification of brain tumor biopsy HRMAS spectra. We also demonstrate the quality of the LCModel fit for the four main brain tumor types (astrocytoma grade II, glioblastoma, metastasis, and meningioma). Our data suggest that when fitting resonances of coupled spins systems in high‐resolution spectra, interactions between metabolites and the macromolecular environment of the biopsy may cause small peak shifts not found in the solution spectra. However, LCModel is shown to provide a user‐independent method of analyzing HRMAS brain tumor spectra. Magn Reson Med, 2008.
- 29 July 2008
- Published by Wiley in NMR in Biomedicine
- Vol. 21 (10) , 1138-1147
An assessment of the effects of sample ischaemia and spinning time on the metabolic profile of brain tumour biopsy specimens as determined by high‐resolution magic angle spinning 1H NMR
High‐resolution magic angle spinning (HRMAS) 1H NMR of biopsy tissue provides a biochemical profile that has potential diagnostic and prognostic value, and can aid interpretation of the lower‐resolution 1H‐NMR spectra obtained in vivo. However, the biochemical profile obtained may be affected by experimental factors such as a period of ischaemia before snap‐freezing of the biopsy tissue for subsequent analysis and the mechanical stress of the spinning procedure of HRMAS itself. We have used normal rat brain cortex as a ‘gold standard’, either funnel‐frozen or deliberately allowed to become ischaemic for set periods of time before snap‐freezing, to quantitatively investigate these two effects. In addition, we have compared biochemical changes that occur in normal rat brain during HRMAS (spun continuously at 5 kHz for 4 h at 4°C as could be required for a two‐dimensional acquisition) with those that occur in biopsy samples from low‐grade and high‐grade adult human astrocytomas, during the same HRMAS procedure. Significant changes due to delayed initial sample freezing were noted in metabolites associated with glycolysis (alanine, glucose and lactate), as expected. However, for the funnel‐frozen rat tissue at 4°C, there were even more significant changes, which appear to be the result of extended spinning at 5 kHz. In particular, the 18% total creatine increase observed is unlikely to be de novo synthesis of creatine. More likely, the asymptotic exponential increase in creatine suggests an exponential release of an NMR‐invisible bound creatine store as a result of tissue damage from mechanical stress of sample spinning. Overall, it appears that tissue ischaemia during biopsy excision and delays in snap‐freezing may have less significant effects on metabolite profile than the prolonged spinning times required for two‐dimensional HRMAS, and this must be accounted for when results are being interpreted. Copyright © 2008 John Wiley & Sons, Ltd.
- 29 July 2008
- Published by Wiley in NMR in Biomedicine
- Vol. 21 (10) , 1138-1147
An assessment of the effects of sample ischaemia and spinning time on the metabolic profile of brain tumour biopsy specimens as determined by high‐resolution magic angle spinning 1H NMR
High‐resolution magic angle spinning (HRMAS) 1H NMR of biopsy tissue provides a biochemical profile that has potential diagnostic and prognostic value, and can aid interpretation of the lower‐resolution 1H‐NMR spectra obtained in vivo. However, the biochemical profile obtained may be affected by experimental factors such as a period of ischaemia before snap‐freezing of the biopsy tissue for subsequent analysis and the mechanical stress of the spinning procedure of HRMAS itself. We have used normal rat brain cortex as a ‘gold standard’, either funnel‐frozen or deliberately allowed to become ischaemic for set periods of time before snap‐freezing, to quantitatively investigate these two effects. In addition, we have compared biochemical changes that occur in normal rat brain during HRMAS (spun continuously at 5 kHz for 4 h at 4°C as could be required for a two‐dimensional acquisition) with those that occur in biopsy samples from low‐grade and high‐grade adult human astrocytomas, during the same HRMAS procedure. Significant changes due to delayed initial sample freezing were noted in metabolites associated with glycolysis (alanine, glucose and lactate), as expected. However, for the funnel‐frozen rat tissue at 4°C, there were even more significant changes, which appear to be the result of extended spinning at 5 kHz. In particular, the 18% total creatine increase observed is unlikely to be de novo synthesis of creatine. More likely, the asymptotic exponential increase in creatine suggests an exponential release of an NMR‐invisible bound creatine store as a result of tissue damage from mechanical stress of sample spinning. Overall, it appears that tissue ischaemia during biopsy excision and delays in snap‐freezing may have less significant effects on metabolite profile than the prolonged spinning times required for two‐dimensional HRMAS, and this must be accounted for when results are being interpreted. Copyright © 2008 John Wiley & Sons, Ltd.
- Open Access
- 9 January 2008
- Published by Wiley in NMR in Biomedicine
- Vol. 21 (7) , 677-685
An investigation of human brain tumour lipids by high‐resolution magic angle spinning 1H MRS and histological analysis
NMR‐visible lipid signals detected in vivo by 1H MRS are associated with tumour aggression and believed to arise from cytoplasmic lipid droplets. High‐resolution magic angle spinning (HRMAS) 1H MRS and Nile Red staining were performed on human brain tumour biopsy specimens to investigate how NMR‐visible lipid signals relate to viable cells and levels of necrosis across different grades of glioma. Presaturation spectra were acquired from 24 adult human astrocytoma biopsy samples of grades II (8), III (2) and IV (14) using HRMAS 1H MRS and quantified using LCModel to determine lipid concentrations. Each biopsy sample was then refrozen, cryostat sectioned, and stained with Nile Red, to determine the number of lipid droplets and droplet size distribution, and with Haematoxylin and Eosin, to determine cell density and percentage necrosis. A strong correlation (R = 0.92, P < 0.0001) was found between the number of Nile Red‐stained droplets and the ∼1.3 ppm lipid proton concentration by 1H MRS. Droplet sizes ranged from 1 to 10 µm in diameter, and the size distribution was constant independent of tumour grade. In the non‐necrotic biopsy samples, the number of lipid droplets correlated with cell density, whereas in the necrotic samples, there were greater numbers of droplets that showed a positive correlation with percentage necrosis. The correlation between 1H MRS lipid signals and number of Nile Red‐stained droplets, and the presence of lipid droplets in the non‐necrotic biopsy specimens provide good evidence that the in vivo NMR‐visible lipid signals are cytoplasmic in origin and that formation of lipid droplets precedes necrosis. Copyright © 2008 John Wiley & Sons, Ltd.
- 9 January 2008
- Published by Wiley in NMR in Biomedicine
- Vol. 21 (7) , 677-685
Open AccessAn investigation of human brain tumour lipids by high‐resolution magic angle spinning 1H MRS and histological analysis
NMR‐visible lipid signals detected in vivo by 1H MRS are associated with tumour aggression and believed to arise from cytoplasmic lipid droplets. High‐resolution magic angle spinning (HRMAS) 1H MRS and Nile Red staining were performed on human brain tumour biopsy specimens to investigate how NMR‐visible lipid signals relate to viable cells and levels of necrosis across different grades of glioma. Presaturation spectra were acquired from 24 adult human astrocytoma biopsy samples of grades II (8), III (2) and IV (14) using HRMAS 1H MRS and quantified using LCModel to determine lipid concentrations. Each biopsy sample was then refrozen, cryostat sectioned, and stained with Nile Red, to determine the number of lipid droplets and droplet size distribution, and with Haematoxylin and Eosin, to determine cell density and percentage necrosis. A strong correlation (R = 0.92, P < 0.0001) was found between the number of Nile Red‐stained droplets and the ∼1.3 ppm lipid proton concentration by 1H MRS. Droplet sizes ranged from 1 to 10 µm in diameter, and the size distribution was constant independent of tumour grade. In the non‐necrotic biopsy samples, the number of lipid droplets correlated with cell density, whereas in the necrotic samples, there were greater numbers of droplets that showed a positive correlation with percentage necrosis. The correlation between 1H MRS lipid signals and number of Nile Red‐stained droplets, and the presence of lipid droplets in the non‐necrotic biopsy specimens provide good evidence that the in vivo NMR‐visible lipid signals are cytoplasmic in origin and that formation of lipid droplets precedes necrosis. Copyright © 2008 John Wiley & Sons, Ltd.
- Open Access
- 3 December 2007
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 27 (1) , 178-184
Apparent T2relaxation times of lipid and macromolecules: A study of high‐grade tumor spectra
Purpose To determine T2 relaxation times of lipid and macromolecules (Lip/MMs) observed by 1H magnetic resonance spectroscopy (1H MRS) of metastases (MET) and glioblastomas (GBM), so that they may be better characterized. Materials and Methods 1H spectra were acquired at multiple echo times from brain lesions using point-resolved spectroscopy sequence (PRESS) at TE = 30 msec either with metabolite-nulling (six GBM and 11 MET), or without metabolite-nulling (four MET and one mucocele). All lesions were previously untreated and had subsequent histopathological classification. Results The T2 of the 1.3-ppm Lip/MM peak was concentration-dependent, but at high concentrations it was significantly different (P = 0.015) between GBM (42 ± 6 msec) and MET (63 ± 18 msec). The broad 2.05-ppm and 0.09-ppm Lip/MM peaks had similar T2s in MET and GBM. The T2 of the narrow 2.05-ppm Lip/MM peak sometimes observed had a T2 of 100 ± 17 msec in MET and 75 msec in the mucocele. Conclusion We observed significantly higher T2 of the 1.3-ppm Lip/MM peak in MET compared with GBM at high 1.3-ppm proton concentrations, in agreement with a higher 1.3/0.9-ppm peak ratio found in MET. The relatively long T2 of the 2.05-ppm Lip/MM peak sometimes observed in MET may cause it to be confused with N-acetyl aspartate (NAA). J. Magn. Reson. Imaging 2007.
- 3 December 2007
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 27 (1) , 178-184
Open AccessApparent T2relaxation times of lipid and macromolecules: A study of high‐grade tumor spectra
Purpose To determine T2 relaxation times of lipid and macromolecules (Lip/MMs) observed by 1H magnetic resonance spectroscopy (1H MRS) of metastases (MET) and glioblastomas (GBM), so that they may be better characterized. Materials and Methods 1H spectra were acquired at multiple echo times from brain lesions using point-resolved spectroscopy sequence (PRESS) at TE = 30 msec either with metabolite-nulling (six GBM and 11 MET), or without metabolite-nulling (four MET and one mucocele). All lesions were previously untreated and had subsequent histopathological classification. Results The T2 of the 1.3-ppm Lip/MM peak was concentration-dependent, but at high concentrations it was significantly different (P = 0.015) between GBM (42 ± 6 msec) and MET (63 ± 18 msec). The broad 2.05-ppm and 0.09-ppm Lip/MM peaks had similar T2s in MET and GBM. The T2 of the narrow 2.05-ppm Lip/MM peak sometimes observed had a T2 of 100 ± 17 msec in MET and 75 msec in the mucocele. Conclusion We observed significantly higher T2 of the 1.3-ppm Lip/MM peak in MET compared with GBM at high 1.3-ppm proton concentrations, in agreement with a higher 1.3/0.9-ppm peak ratio found in MET. The relatively long T2 of the 2.05-ppm Lip/MM peak sometimes observed in MET may cause it to be confused with N-acetyl aspartate (NAA). J. Magn. Reson. Imaging 2007.
- 26 February 2007
- Published by Wiley in NMR in Biomedicine
- Vol. 20 (8) , 763-770
Linear discriminant analysis of brain tumour 1H MR spectra: a comparison of classification using whole spectra versus metabolite quantification
1H MRS is an attractive choice for non‐invasively diagnosing brain tumours. Many studies have been performed to create an objective decision support system, but there is not yet a consensus as to the best techniques of MRS acquisition or data processing to be used for optimum classification. In this study, we investigate whether LCModel analysis of short‐TE (30 ms), single‐voxel tumour spectra provide a better input for classification than the use of the original spectra. A total of 145 histologically diagnosed brain tumour spectra were acquired [14 astrocytoma grade II (AS2), 15 astrocytoma grade III (AS3), 42 glioblastoma (GBM), 41 metastases (MET) and 33 meningioma (MNG)], and linear discriminant analyses (LDA) were performed on the LCModel analysis of the spectra and the original spectra. The results consistently suggest improvement in classification when the LCModel concentrations are used. LDA of AS2, MNG and high‐grade tumours (HG, comprising GBM and MET) correctly classified 94% using the LCModel dataset compared with 93% using the spectral dataset. The inclusion of AS3 reduced the accuracy to 82% and 78% for LCModel analysis and the original spectra, respectively, and further separating HG into GBM and MET gave 70% compared with 60%. Generally MNG spectra have profiles that are visually distinct from those of the other tumour types, but the classification accuracy was typically about 80%, with MNG with substantial lipid/macromolecule signals being classified as HG. Omission of the lipid/macromolecule concentrations in the LCModel dataset provided an improvement in classification of MNG (91% compared with 76%). In conclusion, there appears to be an advantage to performing pattern recognition on the quantitative analysis of tumour spectra rather than using the whole spectra. However, the results suggest that a two‐step LDA process may help in classifying the five tumour groups to provide optimum classification of MNG with high lipid/macromolecule contributions which maybe misclassified as HG. Copyright © 2007 John Wiley & Sons, Ltd.
- 26 February 2007
- Published by Wiley in NMR in Biomedicine
- Vol. 20 (8) , 763-770
Linear discriminant analysis of brain tumour 1H MR spectra: a comparison of classification using whole spectra versus metabolite quantification
1H MRS is an attractive choice for non‐invasively diagnosing brain tumours. Many studies have been performed to create an objective decision support system, but there is not yet a consensus as to the best techniques of MRS acquisition or data processing to be used for optimum classification. In this study, we investigate whether LCModel analysis of short‐TE (30 ms), single‐voxel tumour spectra provide a better input for classification than the use of the original spectra. A total of 145 histologically diagnosed brain tumour spectra were acquired [14 astrocytoma grade II (AS2), 15 astrocytoma grade III (AS3), 42 glioblastoma (GBM), 41 metastases (MET) and 33 meningioma (MNG)], and linear discriminant analyses (LDA) were performed on the LCModel analysis of the spectra and the original spectra. The results consistently suggest improvement in classification when the LCModel concentrations are used. LDA of AS2, MNG and high‐grade tumours (HG, comprising GBM and MET) correctly classified 94% using the LCModel dataset compared with 93% using the spectral dataset. The inclusion of AS3 reduced the accuracy to 82% and 78% for LCModel analysis and the original spectra, respectively, and further separating HG into GBM and MET gave 70% compared with 60%. Generally MNG spectra have profiles that are visually distinct from those of the other tumour types, but the classification accuracy was typically about 80%, with MNG with substantial lipid/macromolecule signals being classified as HG. Omission of the lipid/macromolecule concentrations in the LCModel dataset provided an improvement in classification of MNG (91% compared with 76%). In conclusion, there appears to be an advantage to performing pattern recognition on the quantitative analysis of tumour spectra rather than using the whole spectra. However, the results suggest that a two‐step LDA process may help in classifying the five tumour groups to provide optimum classification of MNG with high lipid/macromolecule contributions which maybe misclassified as HG. Copyright © 2007 John Wiley & Sons, Ltd.